# Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-burden-of-breakthrough-hemolysis-in-patients-with-paroxysmal-nocturnal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ioannis Tomazos,J. Rafael Sierra,Karissa Johnston,Antoinette Cheung,Robert A. Brodsky,Ilene C. Weitz |
| Citations | 19 |
| DOI | 10.1080/16078454.2020.1807226 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/16078454.2020.1807226?needAccess=true |
| OpenAlex ID | https://openalex.org/W3081542742 |
| PMID | 32856539 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Antoinette Cheung](https://scholariq.org/researchers/antoinette-cheung/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.